HOXC6 Drives a Therapeutically Targetable Pancreatic Cancer Growth and Metastasis Pathway by Regulating MSK1 and PPP2R2B

Investigators demonstrated that the transcription factor, homeobox C6 (HOXC6), was overexpressed in most PDACs, and its inhibition blocked PDAC tumor growth and metastasis.